Pfizer says it will buy privately held FoldRx Pharmaceuticals for an undisclosed amount, expanding its pipeline of potential products.
FoldRx, based in Cambridge, Massachusetts, is developing potential treatments for diseases caused by protein misfolding, which is increasingly recognized as an underlying cause in many chronic …
No comments:
Post a Comment